Jazz Pharmaceuticals' Lung Cancer Setback: Stock Impact
A late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
Understand when rebalancing triggers capital gains taxes and how to plan for them. This intro highlights key rules and proactive strategies.
23,600 articlesA late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
Bitcoin’s bear market struggle is driving layoffs and automation in crypto firms even as banks and fintechs chase big...
Melius Research initiates Buy ratings on Seagate and Western Digital, signaling roughly 55% upside despite ongoing ch...
Realty Income reports steady AFFO growth, near-full occupancy, and a secure monthly dividend, challenging the narrati...
Apple advances a leadership shift, naming hardware chief John Ternus as the next CEO, effective Sept. 1, 2026. Tim Co...
A surprising slide in Micron shares has investors weighing memory cycles, AI demand, and competitive pressure. This g...
SK hynix began trading in the U.S. on a when-issued basis under the SKHYV symbol, with the permanent SKHY ticker slat...
Rising mortgage rates change buyer behavior and put pressure on single-family demand. This guide explains how mortgag...
Anthropic’s rumored trillion-dollar IPO has investors buzzing, yet a wave of caution surrounds the offering amid valu...
Palantir stock slipped from its peak, triggering questions about value, risk, and timing for late 2026. This guide br...
NVIDIA is broadening beyond GPUs into physical AI robotics, building a global ecosystem and securing China sales, as ...
When a small-cap tech company reports results that miss expectations, the stock often takes a hit. This piece dives i...